Mirza, M R, Benigno, B, Dørum, A, Mahner, S, Bessette, P, Barceló, I B, Berton-Rigaud, D, Ledermann, J A, Rimel, B J, Herrstedt, J, Lau, S, du Bois, A, Herráez, A C, Kalbacher, E, Buscema, J, Lorusso, D, Vergote, I, Levy, T, Wang, P, de Jong, F A, Gupta, D & Matulonis, U A 2020, ' Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo : Results from the phase III ENGOT-OV16/NOVA trial ', Gynecologic Oncology, vol. 159, no. 2, pp. 442-448 . https://doi.org/10.1016/j.ygyno.2020.09.006